To improve the quality of medical care in developing countries, a new partnership between the American Society of Hematology (ASH) and Health Volunteers Overseas (HVO) aims to recruit and support physician volunteers to educate and train health-care providers in those countries on the treatment of patients with blood disorders.
Unique technology, that uses the enzymes of fireflies to read the genetic code of DNA, has been installed at the University of Liverpool.
With a view to prevent any epidemic in flood-hit regions of Maharashtra, the state Directorate of Health Services has stepped up efforts to prevent spread of water borne diseases.
Protecting older children and adults with insecticide-treated bed nets may be an effective way to combat malaria, a study has shown. The research, published today in the open access journal PLoS Medicine, suggests that protecting half of all older children and adults would also protect the wider community from malaria, which kills over one million people each year.
The United Nations Children’s Fund (UNICEF) and France have donated nearly $400,000 worth of anti-malaria drugs to Liberia in a move immediately welcomed by the Government.
Chancellor Larry Hollier, MD, announced that the Louisiana Board of Regents voted to award LSU Health Sciences Center New Orleans a $3.3 million grant and an equal share of a $5.9 million grant from their Research Commercialization and Education Enhancement Program.
The U.S. Food and Drug Administration has cleared for marketing the Binax NOW Malaria Test, the first authorized U.S. rapid test for malaria, a mosquito-borne disease caused by a parasite. The test is intended for laboratory use.
The genes that make up the immune system of the Aedes aegypti mosquito which transmits deadly viral diseases to humans have been identified in new research out today in Science.
More than 1,500 participants from around the world are exchanging lessons learned from their efforts to prevent and treat HIV/AIDS and to care for sufferers at a four-day United Nations-backed meeting in Rwanda.
A review of previous studies indicates that two doses of a malaria preventive therapy during pregnancy provides substantial benefit to HIV-negative women in Africa, with more frequent dosing apparently necessary for HIV-positive women, according to an article in the June 20 issue of JAMA.